Obermatt
See Similar Stocks →

Integra LifeSciences

NSQ:IART · US4579852082
Health Care Equipment & SuppliesLarge

360

21
EV / EBIT75
Price / Owner Earnings62
Owner Earnings Yield1
Dividend Yield1
Price/Sales83
EV / Gross Profit59
Price/Book72
Return on Capital45
Cash Return on Capital28
Return on Equity17
EBIT Margin58
Gross Profitability20
Accruals85
Owner Earnings Margin20
Sales growth23
Profit Growth72
Long-Term EPS Growth56
Reinvestment25
Price momentum86
Debt load17
Refinancing94
Debt Payback1
Liquidity64
Analyst ratings3
Opinion Changes93
Price Target Upside4
Market mood31
Value Creation4/20not creating value
  • Creates more value than its capital costs
  • Owner earnings growing
  • Owner earnings per share growing
  • Reinvests at strong returns
  • Solid earnings base

What this means

Integra LifeSciences doesn't consistently earn more than its cost of capital, so it isn't yet creating shareholder value.

Profile

CountryUSA
IndustryHealth Care Equipment & Supplies
SizeLarge
TypePublic Company
ExchangeNASDAQGS
Founded1989
Employees3,138
Websiteintegralife.com
ISINUS4579852082
Last UpdateApr 2, 2026
Indices
NASDAQ (USA)D.J. US Medical Equipment
Themes
Injection MoldingEar Nose & Throat (ENT)Biomedical EngineeringNeurologyOrthopaedicsSurgery

Description

Integra LifeSciences Holdings Corporation (Integra) operates as a global medical technology company dedicated to restoring lives. The company is advancing transformational care through impactful innovation, and its portfolio of highly differentiated…

Analysis

Middle-of-the-road

Integra LifeSciences Holdings Corporation sits in the middle of our grid: average quality, average price, no obvious signal in either direction.

Valuation data is not available for this company.

Growth is moderate; the safety picture is fragile. The company scores 4/20 on our value-creation score: not creating value.

No flags apply to this company at this time: accounts, balance sheet, and cash quality all pass. A clean bill of health is meaningful, not just the absence of a warning. This analysis describes numbers; it is not investment advice.

360° rank · history

1007550250
59
2023202420252026

All-time high

86

Jan 2023

All-time low

1

Mar 2025

Average rank

31

across all years

Detailed & Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history.

Current202520242023
Price/Sales
83
79
64
61
Price/Earnings
51
96
95
71
Price/Book
72
78
74
75
Dividend Yield
1
1
1
1
Value (overall)
76
87
86
80

Cells are coloured by rank band (red weak → green strong). Sentiment & 360° history begins 2023.

Similar Stocks

The companies this stock is ranked against.

Compare Integra LifeSciences with its peers
SS Innovations International
NAQ:SSII
26
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
CONMED
NYQ:CNMD
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Ceribell
NSQ:CBLL
37
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Pulse Biosciences
NAQ:PLSE
45
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →
Edwards Lifesciences
NYQ:EW
55
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeX-Large
Full Stock Analysis →
Sight Sciences
NSQ:SGHT
44
CountryUSA
IndustryHealth Care Equipment & Supplies
SizeSmall
Full Stock Analysis →

Make Sense of the Ranks

Every rank runs 1–100 against true peers. Higher is always better.

360° View
1 · Watch OutGood· 100
Value
1 · ExpensiveGood Value· 100
Quality
1 · Weak FundamentalsHigh Quality· 100
Growth
1 · Tough TimesHigh Growth· 100
Safety
1 · High LeverageWell-Financed· 100
Sentiment
1 · SkepticismPositive· 100
Learn More →